Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small-cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study.

Harry J. M. Groen, Wallace L. Akerley, Pierre Jean Souquet, Eckart Laack, Ji-Youn Han, Egbert F. Smit, Aaron Scott Mansfield, Edward B. Garon, Juergen Wolf, Daniel Shao-Weng Tan, Rebecca Suk Heist, Maeve Waldron-Lynch, Sylvie Le Mouhaer, Ngozi Nwana, Monica Giovannini, Sergey Orlov


Originele taal-2English
Aantal pagina's2
TijdschriftJournal of Clinical Oncology
Nummer van het tijdschrift15
StatusPublished - 20-mei-2020

Citeer dit